The history of the use of phosphodiesterase-5 inhibitors in the pharmacotherapy of erectile dysfunction (EG) began on March 27, 1998, after the FDA approved sildenafil citrate for clinical usе. This drug made a real revolution in the treatment of erectile dysfunction,
Certain aspects of the effectiveness and safety of using sildenafil citrate in urological practice
The history of the use of phosphodiesterase-5 inhibitors in the pharmacotherapy of erectile dysfunction (EG) began on March 27, 1998, after the FDA approved sildenafil citrate for clinical usе. This drug made a real revolution in the treatment of erectile dysfunction,